Efficacy of citalopram in anorexia nervosa: A pilot study

European Neuropsychopharmacology

Volumn 12, Issue 5, 2002, Pages 453-459

  Fassino, Secondo ^a   Leombruni, Paolo ^a   Daga, Giovanni Abbate ^a   Brustolin, Annalisa ^a   Migliaretti, Giuseppe ^a   Cavallo, Franco ^a   Rovera, Giovanni G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Anorexia nervosa; Citalopram; Selective serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; LORAZEPAM;

ADOLESCENT; ADULT; ANGER; ANOREXIA NERVOSA; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HUMAN; IMPULSIVENESS; INTERVIEW; MAJOR CLINICAL STUDY; OBSESSION; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT OUTCOME; WEIGHT GAIN;

ADOLESCENT; ADULT; AMBULATORY CARE; ANOREXIA NERVOSA; BODY MASS INDEX; BODY WEIGHT; CITALOPRAM; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; PILOT PROJECTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0036788035     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(02)00058-5     Document Type: Article

References (42)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. American Psychiatric Press, Washington, DC.
2. Attia E., Haiman C., Walsh T., Flater S.R. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am. J. Psychiatry. 155:1998;548-551.
3. Beck A.T. Beck Depression Inventory. 1978;Centre for Cognitive Therapy, Philadelphia, PA.
4. Bergh C., Eriksson M., Lindberg G., Sodersten P. Selective serotonin reuptake inhibitors in anorexia. Lancet. 348:1996;1459-1460.
5. Bezchlibnyk-Butler K., Aleksic I., Kennedy S.H. Citalopram: a review of pharmacological and clinical effects. J. Psychiatry Neurosci. 25:2000;241-254.
6. Boris H.N. On the treatment of anorexia nervosa. Int. J. Psychoanal. 65:(pt 4):1984;435-442.
7. Calandra C., Gulino V., Inserra L., Giuffrida A. The use of citalopram in an integrated approach to the treatment of eating disorders: an open study. Eat. Weight Disord. 4:1999;207-210.
8. Casper R.C. Personality features of women with good outcome from restricting anorexia nervosa. Psychosom. Med. 52:1990;156-170.
9. Cloninger C.R., Svrakic D.M., Przybeck T.R. A psychobiological model of temperament and character. Arch. Gen. Psychiatry. 50:1993;975-990.
10. 2A gene promoter polymorphism anorexia nervosa. Lancet. 350:1997;412.
11. Crisp A.H., Lacey J.H., Crutchfield M. Clomipramine and 'drive' in people with anorexia nervosa. Br. J. Psychiatry. 150:1987;355-358.
12. Derogatis L. Symptom Checklist-90 Manual. 1977;Johns Hopkins University Press, Baltimore, MD.
13. 2A promoter polymorphism: 1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet. 351:1998;1785.
14. Fassino S., Abbate Daga G., Garzaro L., Rovera G.G. Earliest recollections in anorexia and bulimia. Eat. Weight Disord. 3:(2):1998;53-63.
15. Fassino S., Abbate Daga G., Amianto F., Leombruni P., Fornas B., Garzaro L., D'Ambrosio G., Rovera G.G. Outcome predictors in anorectic patients after 6 months of multimodal treatment. Psychother. Psychosom. 70:(4):2001;201-208.
16. Fassino S., Abbate Daga G., Pierò A., Leombruni P., Rovera G.G. Anger and personality in eating disorders. J. Psychosom. Res. 51:2001;757-764.
17. Feighner J.P., Overo K. Multicenter, placebo controlled, fixed-dose study of citalopram in moderate-to-severe depression. J. Clin. Psychiatry. 60:1999;824-830.
18. Ferguson C.P., La Via M.C., Crossan P.J., Kaye W.H. Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa? Int. J. Eat. Disord. 25:1999;11-17.
19. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. The structured clinical interview for DSM-III-R personality disorders (SCID-II). Part I: description. J. Pers. Disord. 9:(2):1995;83-91.
20. Garner D. Eating Disorder Inventory 2: Professional Manual. 1991;Psychological Assessment Resources, Odessa, FL.
21. Goldberg S.C., Halmi K.A., Eckert E.D., Casper R.C., Davis J.M. Cyproheptadine in anorexia nervosa. Br. J. Psychiatry. 134:1979;67-70.
22. Gwirtsman H.E., Guze B.H., Yager J., Gainsley B. Fluoxetine treatment of anorexia nervosa: an open clinical trial. J. Clin. Psychiatry. 51:1990;378-382.
23. Halmi K.A., Eckert E., LaDu T.J., Cohen J. Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline. Arch. Gen. Psychiatry. 43:1986;177-181.
24. Herzog D.B., Keller M.B., Strober M., Yeh C.J., Pal S.Y. The current status of treatment for anorexia nervosa. Int. J. Eat. Disord. 12:1992;215-220.
25. Hudson J.I., Pope H.G. Jr., Jonas J.M., Yurgelun Todd D. Treatment of anorexia nervosa with antidepressants. J. Clin. Psychopharmacol. 5:1985;17-23.
26. Johnson C., Stuckey M., Mitchell J. Psychopharmacological treatment of anorexia nervosa and bulimia. Review and synthesis. J. Nerv. Ment. Dis. 171:1983;524-534.
27. Jimerson D.C., Wolfe B.E., Brothman A.W., Metzger E.D. Medications in the treatment of eating disorders. Psychiatr. Clin. North Am. 19:1996;739-754.
28. Kaye W.H. Relapse prevention with fluoxetine in anorexia nervosa: a double-blind placebo controlled study. New Research Program and Abstracts of the 150th Annual Meeting of the American Psychiatric Association; May 17-22, 1997. Journal of Clinical Psychiatry, San Diego.
29. Kaye, W.H., Weltzin, T.E., Hsu, L.K.G., Bulik, C.M., 1991. An open trial of fluoxetine in patients with anorexia nervosa 52, 464-471.
30. Kaye W., Gendall K., Strober M. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biol. Psychiatry. 44:1998;825-838.
31. Kaye W., Strober M., Stein D., Gendall K. New directions in treatment research of anorexia and bulimia nervosa. Biol. Psychiatry. 45:1999;1285-1292.
32. Keen D.R. Anorexia nervosa: an adlerian perspective on etiology and treatment. Individual Psychol. 52:1996;385-405.
33. Lacey J.H. Self-damaging and addictive behaviour in bulimia nervosa. A catchment area study. Br. J. Psychiatry. 163:1993;190-194.
34. Lilenfeld L.R., Kaye W.H., Strober M. Genetics and family studies of anorexia nervosa and bulimia nervosa. Jimerson D.C., Kaye W.H., Bailliere's Clinical Psychiatry. Vol. 3. Eating Disorders:1997;177-197 Bailliere Tindall, London.
35. Montgomery S.A. Alternatives to placebo-controlled trials in psychiatry. Eur. Neuropsychopharmacol. 9:1999;265-269.
36. Nagata T., Kawarada Y., Kiriike N., Iketani T. Multi-impulsivity of Japanese patients with eating disorders: primary and secondary impulsivity. Psychiatry Res. 94:2000;239-250.
37. Papakostas Y.G., Daras M.D. Placebos, placebo effect, and the response to the healing situation: the evolution of a concept. Epilepsia. 42:2001;1614-1625.
38. Raitasuo S., Virtanen H., Raitasuo J. Anorexia nervosa, major depression, and obsessive-compulsive disorder in a Down's syndrome patient. Int. J. Eat. Disord. 23:1998;107-109.
39. Spielberger C.D. Manual for the State-Trait Anxiety Inventory, Revised. 1983;Consulting Psychologists Press, Palo Alto.
40. Strober M., Freeman R., Morrell W. The long-term course of severe anorexia nervosa in adolescents: survival analysis of recovery, relapse, and outcome predictors over 10-15 years in a prospective study. Int. J. Eat. Disord. 22:1997;339-360.
41. Tan J.Y., Levin G.M. Citalopram in the treatment of depression and other potential uses in psychiatry. Pharmacotherapy. 19:1999;675-689.
42. Vigersky R.A., Loriaux D.L. The effect of cyproheptadine in anorexia nervosa: a double blind trial. Vigersky R.A., Anorexia Nervosa. 1977;Raven Press, New York.